2 insiders reported 6 Form 4 transactions for Grace Therapeutics, Inc. (GRCE) over the past 18 months (most recent 2026-09-23). Recent activity: Opaleye Management Inc. (10% Owner) Buy 5,318 shares, Opaleye Management Inc. (10% Owner) Buy 9,771 shares, Opaleye Management Inc. (10% Owner) Buy 5,836 shares, Opaleye Management Inc. (10% Owner) Buy 9,393 shares, Kohli Prashant (Chief Executive Officer) Buy 100,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-23 | Opaleye Management Inc. | 10% Owner | Buy | 5,318 | $11,168 |
| 2026-09-23 | Opaleye Management Inc. | 10% Owner | Buy | 9,771 | $20,519 |
| 2026-09-10 | Opaleye Management Inc. | 10% Owner | Buy | 5,836 | $12,197 |
| 2026-09-10 | Opaleye Management Inc. | 10% Owner | Buy | 9,393 | $19,699 |
| 2026-09-10 | Kohli Prashant | Chief Executive Officer | Buy | 100,000 | $214,000 |
| 2026-08-19 | Opaleye Management Inc. | 10% Owner | Buy | 11,608 | $24,206 |
来源：SEC Form 4 申报文件 · 截至 2026-09-23